- Gounder Brings Clarity to Egg Freezing, AI Virus Creation, and New Trump Vaccine Order
- 3 states take steps to restrict kratom
- Ochsner CEO: How listening changed the way I lead
- Leading through disruption: 6 ways healthcare CEOs turn trends into strategic advantage
- What’s keeping 11 behavioral health leaders up at night
- Providence to completely exit insurance business after Medicare Advantage deal falls through
- What a children’s hospital learned from the Blue Angels
- CorroHealth executive joins 2026 PRNEWS People of the Year class
- How Allina Health’s AI operating system drove $7.3M in added annual surgical contribution margin
- Total enrollment for 73 dental schools in the U.S.
- 55 hospital and health system CISOs and chief privacy officers to know | 2026
- What’s driving Providence’s $400M turnaround
- The dental specialty seeing the largest drop in education enrollment
- Women’s hospital, health system leadership representation ticks up in 2026
- 4 recent hospital, health system CFO exits
- Dental school enrollment up 10% since 2021
- Heartland Dental ranks among best-in-state employers: Forbes
- Virginia dental practice opens 5th location
- The 5 highest-paid cardiologists in Kansas City
- 8 federal government, policy updates for dental leaders to know
- Florida oral surgery practice damaged in fire
- 6 DSOs making headlines
- How AI is reshaping behavioral healthcare
- DermCare Management, US Dermatology Partners form national dermatology group
- 29 new behavioral health study findings to know
- The real reason ASC anesthesia departments struggle — and it’s not operations
- Nevada cuts psychiatric residential placements for children from 35% to 16%
- States Enact Emergency Orders On Kratom While Awaiting Federal Rules
- Seattle Children’s expands with $103M ASC
- 5 cardiologists in the headlines
- The toughest talks ASC leaders have with physicians
- Alabama developers to break ground on $35M ASC
- The specialties driving ASC growth through 2031
- Is the behavioral health access problem actually a quality problem?
- Nurses at SSM Health outpatient practices move to unionize
- 62% of ASCs cancel, delay cases over anesthesia gaps
- Study examines how ICHRA adoption could help stabilize ACA risk pools
- Winter Is Coming: How Vaccines Help Protect Against Respiratory Illness
- Screen Time Is Not All Bad For Kids' Brains
- Processed Foods Linked To Prostate Cancer Risk
- Patient advocacy group sues AMA for open access to CPT system
- Updated Statement Regarding the Division of Corporation Finance’s Role in the Exchange Act Rule 14a-8 Process
- Luigi Mangione pleads guilty in federal case over murder of UnitedHealthcare CEO Brian Thompson
- It's BMS vs. Celgene investors once more after US appeals court revives lawsuit
- Industry Voices—AI should help cancer patients survive the healthcare system
- Tavneos trial flagged for 'serious breaches' of protocol as EU regulators dissect market withdrawal decision
- Insurers denied between 12% to 18% of prior authorization requests in 2025: KFF
- Sleep Disturbances Linked To Genetic Alzheimer's Risk
- Pre-K Sets Kids Up For School Success, Study Says
- Expect Other Seniors To Act Their Age? Then Expect Problems With Your Own Memory, Study Says
- A genomics library for the AI era
- BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod
- People With Disabilities Say Medicaid Income Limits Stifle Career Advancement
- Trump Team’s Use of Arcane Budget Rule Threatens Medicaid Coverage
- My Husband Was Kicked Out of Hospice for Dying Too Slowly
- Massachusetts moves to restrict kratom sales
- Meet the leaders of the fastest-growing dental practices
- Fierce Pharma Asia—Legend’s first profit; Taiho, Cullinan’s EGFR win; WuXi AppTec’s reprieve
- 5 numbers making dentists optimistic
- 25 state behavioral health policy updates
- Mental healthcare provider gaps, by state
- Hippocratic AI rolls out platform to coordinate teams of conversational voice AI agents
- 23 new behavioral health projects to know
- Major PBMs agree to offer TrumpRx pricing information to members
- Providence reports $400M operating improvement halfway through 2026
- A look at where Aetna is seeing value-based care success in Medicare Advantage
- Rare Bacteria In Coastal Waters Has Killed 7 This Summer
- It's crunch time for Karyopharm as company faces potential default next month
- March of Dimes: Maternity care deserts persist, Medicaid cuts threaten to curb access further
- Trump administration refers providers, PBMs to DOJ over youth gender care billing
- Socializing: A Prescription For Healthier Brain Aging
- Taking The Stairs May Lower Your Risk Of Dying From Heart Disease
- Weekly Rundown: US News rates GLP-1 telehealth platforms; CHAI launches AI cybersecurity work group
- Obesity not a 'zero-sum game' as patients crave optionality, Novo CEO says: Reuters
- AZ's blood pressure newcomer Baxfendy fails to meet cost-effectiveness bar, ICER says
- Sweet Tooth? It Could Be Shaping Your Decisions, Study Says
- Stressed Parents Turn To Screens For Help, Study Finds
- Gambling Linked To Mental Health Problems Among College Students
- Hospitals Say They Found A Tool To Help Reduce Childbirth Risks: Wristbands
- Listen to the Latest ‘KFF Health News Minute’
- Readers Speak Out on Work Requirements, Federal Data Grab, Opioid Payback Cash
- People With Disabilities Say Medicaid’s Limits on Income Stifle Career Advancement
- Abbott to pump up blood supply with $1M college sports prize amid US crisis
- Neurocrine stands by blockbuster hopeful Vykat XR as Prader-Willi docs raise potential safety flags
- Appeals court tosses methodology for calculating NSA qualifying payment amounts
- UC San Diego Health, West Health launch $40M accelerator for 'tech-forward' coordinated care
- Epic releases Care Everywhere diagnostic image exchange to tackle healthcare's 'CD problem'
- FDA Wants More Information From Food Makers On New Food Chemicals
- Cityblock unveils partnership with Humana in North Carolina
- Antelope Recovery, offering SUD care for teens, to expand Spanish services in Colorado
- Legend interim CEO talks rising competition as Carvykti maker posts first profit
- Aspirin/Omega-3 Combo Matches Antibiotics In Treating Gum Disease, Trial Finds
- Endometriosis Linked To Higher Type 2 Diabetes Risk
- Cedar launches Kora Platform to build out agentic AI for medical billing
- Sharp HealthCare announces another reorganization affecting 260 workers
- Alfasigma gains arthritis drug, access to new markets with M&A play
- Common Health Coalition secures $100M from OpenAI Foundation to boost hepatitis C cure rates
- Lilly takes 6 companies to court for selling retatrutide knockoffs
- Tamiflu Helps Keep Severely Ill Kids Out Of The ICU, Study Finds
- 'Normal' Can Backfire During Doctor/Patient Discussions
- Experimental Pulse Oximeter Accurate Regardless Of Skin Tone, Researchers Say
- Suvi Health launches ambient AI solution for patients to reduce hospital stays and support care transitions
- The biggest payer and provider trends from Q2
- Patients Wary Of Governments, Companies Pushing AI As A Rural Healthcare Solution
- Hospital Prepayment Requirements Add New Wrinkles to Patients’ Financial Responsibility
- Hospitals Say They Found a Tool To Help Reduce Childbirth Risks: Wristbands
- Years After He Quit Smoking, a Lung Cancer Scan Saved His Life
- Fresenius pulls one batch of Actemra biosim over glass particle concerns
- Oracle Health debuts revamped patient portal with an AI upgrade
- Snapchat creates ad format to support pharma disclosure needs
- Assort Health rolls out AI agent to automate referrals for specialty practices and health systems
- Executive Order Calls For Fewer Routine Childhood Vaccines, Doctors Push Back
- Biopharma saw a Q2 sales boom led by Lilly, Sanofi, Regeneron and Astellas
- Real-World Performance Of Alzheimer's Drug, Leqembi, Matches Trial Data, Study Finds
- Study Finds Undisclosed Chemicals In Most Personal Care Products
- Attruby cruises toward blockbuster land as BridgeBio CEO spots ‘stabilizer-first’ ATTR market
- WuXi AppTec scores temporary win amid fight over DOD's Chinese military company brand
- Barbie And Ken Fade From Fantasy, Offer More Realistic Proportions, Study Finds
- Children Should Get Flu Vaccine, Top Pediatrics Group Recommends
- Together, Two Everyday Health Factors Double Death Risk In Midlife And Beyond
- Many States Cover Doula Care, But Access To A 'Birthing Bestie' Is Often Out Of Reach
- A Federal Policy Is Complicating How Organizations Battle the Opioid Crisis
- Chairman Paul S. Atkins Letter to Robert Walley, Chair, CAT NMS Plan Operating Committee
- Trump signs executive order to overhaul pediatric vaccine recommendations
- Unapproved in US for decades, levosimendan stumbles in phase 3 as Tenax eyes narrow FDA path
- Jalapeño Recall Reaches Seven Grocery Chains In 26 States
- New Melanoma Drug, Tudriqev, Based On Herpes Virus Granted FDA Accelerated Approval
- Even Light Exercise May Lower Stroke Risk For People With A-fib
- Working At Home Makes Breastfeeding Harder, Not Easier, Study Says
- Kidney Dialysis: Here's What You Need To Know
- What 524B and QMSR Change About Medical Device Risk
- Taking Lean Manufacturing to the Next Level
- Why Few MedTech Sales Teams Are Using AI Where It Matters Most
- ITM neuroendocrine tumor drug spurned by FDA over manufacturing qualms
- Abbott casts telenovela star Gabriela Spanic to take the drama out of colon cancer screening
- Zepbound Lowers Heart Attack, Stroke Risk Among Type 2 Diabetics
- Heart Problems Linked To Brain Shrinkage Among People With Genetic Risk For Alzheimer's
- Budget Battle Erupts In Nation's Capital Over Opioid Settlement Money
- Rising Global Heat Linked To Mental Health Risks In Children
- Why Organizations Miss Emerging Product Risk: Understanding the engineering mechanisms that remain hidden long before complaint trends become visible
- Update on the SEC’s Work Toward Treasury Clearing Implementation [August 2026]
- FDA Reverses Course, Approves First mRNA Flu Shot
- Therapy Dogs Aid Stroke Rehab
- Leo Pharma readies rare disease education push for 2nd annual GPP awareness day
- The Interface is the Risk: A MedTech Blueprint for AI and System Integration
- Restoring Regulatory Clarity: Statement on Technical Amendments to Rule 0‑1(a)(7)
- Beyond the Status Report: Using LLMs to Reveal the True State of SaMD Development
- Headstands and Summervaults: A Statement on Crypto Vaults and Lending Strategies
- Remarks at the Small Business Capital Formation Advisory Committee Meeting
- Seeking Public Comment on Seeking Public Capital: Remarks Before the Small Business Capital Formation Advisory Committee
Michigan healthcare freedom community forum
Michigan's official vaccine stance was never in doubt, but those who like details will enjoy today's MDHHS Press Release.
I've highlighted the core argument in bold font.
https://www.michigan.gov/mdhhs/inside-mdhhs/newsroom/2025/09/19/standing-rec
State’s Chief Medical Executive Dr. Natasha Bagdasarian makes Standing Recommendation on COVID-19 vaccines
Determines not receiving a dose of COVID-19 vaccine to be an underlying conditionLANSING, Mich. - In response to Gov. Gretchen Whitmer’s Executive Directive to state agencies to ensure Michigan families can access COVID-19 vaccines, the state’s Chief Medical Executive Dr. Natasha Bagdasarian has issued a Standing Recommendation for the COVID-19 vaccine.
“National medical organizations and scientific experts continue to recommend routine COVID-19 vaccination for those at high risk, but also recommend vaccines be made available for all those who want them, ages six months and older,” said Bagdasarian. “COVID-19 vaccines have been proven to reduce the likelihood of emergency department or urgent care visits, as well as hospitalizations and severe outcomes. They are one of our best defenses against the virus. As the state’s chief medical executive, it is my duty to protect and promote public health, and everyone deserves the opportunity to access COVID-19 vaccine if they desire one. This Standing Recommendation will help to protect vaccine accessibility and availability in our state.”
On Wednesday, Aug. 27, the U.S. Food and Drug Administration (FDA) approved the 2025-2026 vaccine for those 65 years of age and older and those ages 5 through 64 years with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19. However, the FDA did not define the list of underlying conditions. The Centers for Disease Control and Prevention’s list includes conditions such as obesity and physical inactivity and states it is “not exhaustive” and “should not be used to exclude people with underlying conditions from recommended measures for prevention or treatment of COVID-19.”
In her recommendation, Bagdasarian stated, “Any person over the age of six months without contraindication who has not received a dose of a Food and Drug Administration (FDA)-approved or -authorized 2025-2026 COVID-19 vaccine may be considered to have an underlying condition that puts them at high risk for severe outcomes from COVID-19 and is thus eligible to receive an age-appropriate dose.”
The Michigan Department of Health and Human Services (MDHHS) continues to recommend the COVID-19 vaccine in alignment with the American Academy of Pediatrics, the American Academy of Family Physicians, and the American College of Obstetricians and Gynecologists.
To help ensure insurance coverage and availability of COVID-19 vaccines as outlined in the Executive Directive, MDHHS is working with the Department of Insurance and Financial Services and the Michigan Department of Licensing and Regulatory Affairs.
To learn more about COVID-19 and seasonal respiratory illnesses and how to protect yourself, visit Michigan.gov/COVIDFluRSV.
# # #
In the game of governments and vaccine policy, looks like the ball is back in the Trump Administration's court. Any bets on Medicaid funding playing a major role?
LARA just issued the same presser under the subject line, "Sharing on behalf of MDHHS."
No other comment, but an early signal to every licensed health professional in Michigan that compliance is expected.
Also Friday, the CDC's recommendation changed.
My favorite part: "shared clinical decision-making." ❤️ 🥂
Close second: MedPage again referencing "pregnant women." 😊
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/117567
CDC Panel Stops Endorsing COVID Shots, Pushes for 'Choice'
— RFK Jr.'s committee breaks from flu shot model, leaves it up to individuals to decide
by Terrence Rudd, Staff Writer, MedPage Today
September 19, 2025The CDC's vaccine advisory committee is no longer recommending the COVID-19 shot for specific groups of Americans, but instead stressing shared clinical decision-making in its newest recommendations.
The Advisory Committee on Immunization Practices (ACIP) on Friday unanimously voted 12-0 to update its recommendations for pediatric and adult immunization schedules, but it deviated from recent FDA vaccine approval language by simply calling for "individual-based decision-making" in everyone ages 6 months and older.
For those 6 months to 64 years, this was paired with recommended language that added "an emphasis that the risk-benefit of vaccination is most favorable for individuals who are at an increased risk for severe COVID-19 disease and lowest for individuals who are not at an increased risk, according to the CDC list of COVID-19 risk factors."
Until now, the vaccinations had been recommended as a routine step in the fall for nearly all Americans who wanted them -- just like a yearly flu vaccine.
Not everything earned unanimous support during the meeting. A motion to recommend that prescriptions be required to get a COVID vaccine led to a deadlocked 6-6 vote, with ACIP Chair Martin Kulldorff, PhD, formerly of Harvard Medical School in Boston, using his tie-breaking power to kill the proposal.
Panelists worried that the prescription proposal could cut pharmacists -- who administer more than 90% of all COVID shots but can't write prescriptions under Medicare Part B rules -- from the ranks of vaccination providers. The effects could slash access and clog primary care providers' offices, some members cautioned.
A third motion to strengthen discussions with patients about COVID vaccination risks and benefits also earned unanimous 12-0 approval. That recommendation calls for discussion of known risk factors for severe COVID outcomes, including age, prior infections, immunosuppression, and other comorbidities identified by the CDC, as well as "a discussion of the potential benefits and risks of vaccination and related uncertainties, especially those outlined in the vaccine information statement, as part of informed consent."
A fourth recommendation encouraged the CDC to promote more consistent, comprehensive informed consent processes, and to encourage the addition of descriptions of six risks and uncertainties outlined by ACIP member and COVID-19 working group chair Retsef Levi, PhD, of the Massachusetts Institute of Technology Sloan School of Management in Boston. That motion passed on an 11-1 vote.
Kulldorff emphasized that the vaccination schedule recommendations won't affect vaccine access in the Vaccines for Children Program -- the federally run program that covers vaccines for about half of children in the U.S.
Sean O'Leary, MD, of the American Academy of Pediatrics (AAP), said the panel's daylong debate involved clear efforts to "sow distrust" about vaccines and would have "real-time impacts on American children."
But he expressed relief that people could instead follow guidelines from his and other medical groups that still recommend the vaccines be available, like in prior years.
"It was a very, very strange meeting," O'Leary said.
A Festivus of Vaccine Uncertainties
In June, HHS Secretary Robert F. Kennedy Jr. sacked the 17 former members of ACIP and replaced them with members more aligned with his views. During the meeting, new members put plenty of focus on COVID vaccines' perceived unknown risks and uncertain benefits.
The discussion featured contentious topics including alleged DNA alterations by mRNA vaccines and case reports of myocarditis in vaccinated people, assertions that mRNA vaccines don't work as intended, the existence of a post-vaccination syndrome, and potential connections between the vaccines and conditions such as birth defects and cancer.
In a presentation to the panel, CDC COVID-19 workgroup member Henry Bernstein, DO, of the Zucker School of Medicine at Hofstra/Northwell in New York, delivered a stinging dissent to the panel's skeptical tone. The former ACIP member called for continued vaccination coverage for a wide range of populations, including pregnant women, children younger than 2 years, older adults, "and anyone who feels they want protection for themselves and their families."
"If we don't want to say vaccines are 'safe and effective,' well, they work!" Bernstein said.
ACIP, FDA, and Medical Organizations Sing Separate Tunes
Last month, the FDA approved updated COVID vaccines for the 2025-2026 respiratory virus season for all adults 65 and older, but limited their use in younger people and children to those with at least one condition that puts them at high risk for severe disease. Kennedy also announced in May that the CDC had dropped its recommendationopens in a new tab or window that healthy children and pregnant women get routine COVID shots.
Those moves prompted multiple medical organizations to issue their own vaccination recommendations, including the AAP, the American College of Obstetricians and Gynecologists (ACOG), the American Academy of Family Physicians (AAFP), and the Society for Maternal-Fetal Medicine (SMFM). The AAP and AAFP said that all children ages 6 to 23 months should be vaccinated against COVID. ACOG, SMFM, and AAFP also recommended that women who are pregnant at any stage or lactating should get a COVID shot.
Health insurer industry group AHIP released a statement Tuesday that backs ACIP's older, broader COVID vaccination recommendations. "Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing for patients through the end of 2026," AHIP said.
On Friday, the Infectious Diseases Society of America (IDSA) again called for Kennedy to resign.
"His leadership has already put up barriers to many Americans' choice to receive the COVID vaccine," said IDSA President Tina Tan, MD, in a statement. "Now he is attacking routine childhood vaccines that have been given broadly and safely for decades, creating chaos and confusion, taking away parents' choices and putting children's lives at significant risk for severe vaccine-preventable diseases."
Typically, ACIP recommendations must be approved by the CDC director, and are not considered final until they are published in the Morbidity and Mortality Weekly Report.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























